샘플 요청 목록

 카트 문의
시장보고서
상품코드
1786432

세계의 심장혈관용 디지털 헬스 시장

Digital Health for Cardiovascular
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 282 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 심장혈관용 디지털 헬스 시장은 2030년까지 1,193억 달러에 도달

2024년에 419억 달러로 추정되는 세계의 심장혈관용 디지털 헬스 시장은 2024-2030년에 CAGR 19.1%로 성장하며, 2030년에는 1,193억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 소프트웨어 컴포넌트는 CAGR 17.0%를 기록하며, 분석 기간 종료시에는 624억 달러에 달할 것으로 예측됩니다. 하드웨어 컴포넌트 분야의 성장률은 분석 기간 중 CAGR 22.1%로 추정됩니다.

미국 시장은 114억 달러, 중국은 CAGR 25.5%로 성장 예측

미국의 심장혈관용 디지털 헬스 시장은 2024년에 114억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 274억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 25.5%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 각각 분석 기간 중 15.4%와 16.9%의 CAGR로 성장할 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 15.9%로 성장할 것으로 예측됩니다.

세계 심혈관 디지털 헬스 시장 - 주요 동향 및 촉진요인 정리

AI와 원격 모니터링이 심혈관 질환의 부담을 줄일 수 있는가?

심혈관 치료에서 디지털 헬스 솔루션의 통합은 인공지능(AI), 원격 환자 모니터링(RPM), 웨어러블 기술을 활용하여 심혈관 건강 상태를 실시간으로 파악함으로써 심장 관련 질환을 관리하는 방법을 재구성하고 있습니다. 심혈관 질환(CVD)은 여전히 전 세계 사망률의 주요 원인으로 지속적인 모니터링과 조기 개입 전략이 필요합니다. AI 기반 알고리즘은 현재 심전도(ECG)를 분석하여 부정맥을 감지하고 잠재적인 심장질환을 미리 예측할 수 있습니다. 스마트워치, 커넥티드 ECG 패치와 같은 원격 모니터링 솔루션을 통해 의사는 환자가 병원을 자주 방문하지 않고도 심박수 변화, 혈압, 부정맥을 추적할 수 있습니다. AI 기반의 가상 비서가 등장하면서 개인 맞춤형 추천, 복약 알림, 생활습관 개선 등을 제공함으로써 환자 참여를 더욱 향상시키고 있습니다. 디지털 심혈관계 솔루션은 조기 발견과 질병 관리를 강화하는 반면, 규제 당국의 승인, 데이터 프라이버시 문제, 상환 정책 등의 문제는 여전히 보급의 장벽으로 작용하고 있습니다. 그러나 AI와 원격 모니터링 기술이 지속적으로 발전함에 따라 보다 능동적이고, 데이터 중심적이며, 접근성이 용이해짐에 따라 심혈관 치료를 변화시킬 준비가 되어 있습니다.

디지털 치료(DTx)는 어떻게 심혈관 결과를 개선할 수 있는가?

디지털 치료(DTx)는 기존 치료법을 보완하는 증거 기반의 소프트웨어 기반 중재를 제공함으로써 심혈관 질환 관리의 강력한 툴로 부상하고 있습니다. 일반적인 웰니스 앱과 달리 DTx 솔루션은 임상적으로 검증되어 고혈압, 고콜레스테롤, 비만과 같은 특정 심혈관 위험 요인을 타겟으로 설계되었습니다. 오마다 헬스(Omada Health)나 리봉고(Livongo)와 같은 기업은 AI를 활용한 디지털 코칭 프로그램을 개발하여 환자가 행동수정 전략을 통해 생활습관 관련 위험요소를 관리할 수 있도록 돕고 있습니다. 또한 지속적인 모니터링 장비와 통합된 디지털 치료제는 실시간 경고 및 중재 권장 사항을 제공하여 급성 심장 사건의 위험을 줄입니다. 가치 기반 의료 모델로의 전환은 보험 프로바이더가 디지털 치료제를 보장하는 원동력이 되고 있으며, 이러한 솔루션이 환자들에게 더 쉽게 접근할 수 있도록 돕고 있습니다. 그러나 규제상의 문제, 의사들의 도입 망설임, 장기적인 임상 검증의 필요성 등이 심혈관계 의료 분야에서 DTx 솔루션의 확산에 여전히 걸림돌로 작용하고 있습니다. 디지털 치료제는 연구를 통해 그 효과가 계속 입증됨에 따라 심혈관 질환 예방 및 관리의 핵심 요소가 될 것으로 기대되고 있습니다.

개인 맞춤형 심혈관 치료에서 AI와 빅데이터의 역할은?

AI와 빅데이터 분석은 개인의 유전적, 대사적, 생활습관적 요인에 기반한 정밀의료 접근을 가능하게 하는 심혈관 치료 계획의 개인화에서 점점 더 중요한 역할을 하고 있습니다. 머신러닝 모델은 전자의무기록(EHR), 유전자 마커, 환자 보고 데이터 등 방대한 데이터세트를 분석하여 심혈관 환자의 개인 맞춤형 치료 경로를 식별하는 데 사용되고 있습니다. AI 기반 위험 예측 모델은 심장병 발병 가능성에 따라 환자를 계층화하여 조기 개입과 표적화된 예방 조치를 가능하게 합니다. 또한 AI 기반 챗봇과 원격의료 플랫폼은 맞춤형 추천을 제공하고, 심혈관 건강 관련 문의에 실시간으로 답변함으로써 환자 참여를 향상시키고 있습니다. 엄청난 잠재력에도 불구하고 심혈관 의료 분야에서 AI의 능력을 최대한 활용하기 위해서는 AI 모델의 편향성, 데이터 상호운용성 문제, 규제 당국의 승인 필요성 등의 문제를 해결해야 합니다. 그러나 빅데이터가 정밀의료의 접근법을 계속 정교화함에 따라 AI는 심혈관 치료 결과를 최적화하는 데 필수적인 역할을 할 것으로 기대되고 있습니다.

심혈관 디지털 헬스 시장의 성장 원동력은?

심혈관 디지털 헬스 시장의 성장은 심장병 유병률 증가, 웨어러블 헬스 기술 채택 증가, AI 기반 진단의 발전 등 여러 가지 요인에 의해 이루어지고 있습니다. 전 세계에서 원격의료 서비스로의 전환으로 원격 환자 모니터링 및 재택 심장 관리 수요가 급증하고 있습니다. 규제 당국도 디지털 건강 개입의 중요성을 인식하고 있으며, 디지털 심혈관계 솔루션에 대한 승인과 상환 지원이 증가하고 있습니다. 블록체인과 사이버 보안 조치의 통합은 환자 데이터의 보안을 강화하고 디지털 헬스 플랫폼에 대한 신뢰를 높이고 있습니다. 또한 정밀의료와 개인 맞춤형 치료 접근법의 부상으로 인해 의료 서비스 프로바이더들은 심혈관 치료에서 AI를 활용한 예측 분석으로 나아가고 있습니다. 디지털 헬스 스타트업에 대한 지속적인 투자와 하이테크 기업, 의료 서비스 프로바이더, 보험사 간의 전략적 제휴를 통해 디지털 심혈관 건강 시장은 크게 성장하고 심장병 관리의 미래를 재구성할 것입니다.

부문

컴포넌트(소프트웨어 컴포넌트, 하드웨어 컴포넌트, 서비스 컴포넌트); 최종 용도(환자, 프로바이더, 지불자, 기타)

조사 대상 기업의 예

  • AliveCor
  • Amwell
  • Cardiogram
  • CardioSignal
  • Cardiovascular Health Solutions
  • Cleerly
  • DarioHealth
  • Eko
  • Fitbit
  • HeartFlow
  • Hello Heart
  • Idoven
  • Lark Health
  • Medtronic
  • Omron Healthcare
  • Philips Healthcare
  • Withings
  • Neko Health
  • Story Health
  • WellDoc

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.19

Global Digital Health for Cardiovascular Market to Reach US$119.3 Billion by 2030

The global market for Digital Health for Cardiovascular estimated at US$41.9 Billion in the year 2024, is expected to reach US$119.3 Billion by 2030, growing at a CAGR of 19.1% over the analysis period 2024-2030. Software Component, one of the segments analyzed in the report, is expected to record a 17.0% CAGR and reach US$62.4 Billion by the end of the analysis period. Growth in the Hardware Component segment is estimated at 22.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.4 Billion While China is Forecast to Grow at 25.5% CAGR

The Digital Health for Cardiovascular market in the U.S. is estimated at US$11.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.4 Billion by the year 2030 trailing a CAGR of 25.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.4% and 16.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.9% CAGR.

Global Digital Health for Cardiovascular Market - Key Trends & Drivers Summarized

Can AI and Remote Monitoring Reduce Cardiovascular Disease Burden?

The integration of digital health solutions in cardiovascular care is reshaping how heart-related diseases are managed, leveraging artificial intelligence (AI), remote patient monitoring (RPM), and wearable technologies to provide real-time insights into cardiovascular health. Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, necessitating continuous monitoring and early intervention strategies. AI-driven algorithms are now capable of analyzing electrocardiograms (ECGs), detecting arrhythmias, and predicting potential cardiac events before they occur. Remote monitoring solutions, such as smartwatches and connected ECG patches, allow physicians to track heart rate variability, blood pressure, and irregular heart rhythms without requiring patients to visit hospitals frequently. The rise of AI-powered virtual health assistants is further improving patient engagement by offering personalized recommendations, medication reminders, and lifestyle modifications. While digital cardiovascular solutions enhance early detection and disease management, challenges such as regulatory approval, data privacy concerns, and reimbursement policies remain barriers to widespread adoption. However, as AI and remote monitoring technologies continue to improve, they are poised to transform cardiovascular care by making it more proactive, data-driven, and accessible.

How Are Digital Therapeutics (DTx) Improving Cardiovascular Outcomes?

Digital therapeutics (DTx) are emerging as a powerful tool in cardiovascular disease management, offering evidence-based, software-driven interventions to complement traditional treatments. Unlike general wellness apps, DTx solutions are clinically validated and designed to target specific cardiovascular risk factors such as hypertension, high cholesterol, and obesity. Companies like Omada Health and Livongo are developing AI-powered digital coaching programs that help patients manage lifestyle-related risk factors through behavior modification strategies. Furthermore, digital therapeutics integrated with continuous monitoring devices provide real-time alerts and intervention recommendations, reducing the risk of acute cardiac events. The shift toward value-based healthcare models is also driving insurance providers to cover digital therapeutics, making these solutions more accessible to patients. However, regulatory challenges, physician adoption hesitancy, and the need for long-term clinical validation remain obstacles to scaling DTx solutions in cardiovascular health. As research continues to demonstrate their effectiveness, digital therapeutics are expected to become a core component of cardiovascular disease prevention and management.

What Role Do AI and Big Data Play in Personalized Cardiovascular Care?

AI and big data analytics are playing an increasingly critical role in personalizing cardiovascular treatment plans, allowing for precision medicine approaches based on an individual's genetic, metabolic, and lifestyle factors. Machine learning models are being used to analyze vast datasets, including electronic health records (EHRs), genetic markers, and patient-reported data, to identify personalized treatment pathways for cardiovascular patients. AI-driven risk prediction models can stratify patients based on their likelihood of developing heart disease, enabling early intervention and targeted preventive measures. Additionally, AI-powered chatbots and telehealth platforms are improving patient engagement by providing tailored recommendations and answering cardiovascular health queries in real time. Despite the immense potential, challenges such as bias in AI models, data interoperability issues, and the need for regulatory approvals must be addressed to unlock the full capabilities of AI in cardiovascular healthcare. However, as big data continues to refine precision medicine approaches, AI is expected to play an indispensable role in optimizing cardiovascular treatment outcomes.

What Is Driving the Growth of the Digital Health for Cardiovascular Market?

The growth in the digital health for cardiovascular market is driven by several factors, including the increasing prevalence of heart diseases, rising adoption of wearable health technologies, and advancements in AI-driven diagnostics. The demand for remote patient monitoring and home-based cardiac care is surging due to the global shift toward telehealth services. Regulatory bodies are also recognizing the importance of digital health interventions, leading to increased approvals and reimbursement support for digital cardiovascular solutions. The integration of blockchain and cybersecurity measures is enhancing patient data security, increasing trust in digital health platforms. Additionally, the rise of precision medicine and personalized treatment approaches is pushing healthcare providers toward AI-powered predictive analytics in cardiovascular care. With continued investment in digital health startups and strategic partnerships among tech companies, healthcare providers, and insurers, the digital cardiovascular health market is set to experience significant growth, reshaping the future of heart disease management.

SCOPE OF STUDY:

The report analyzes the Digital Health for Cardiovascular market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software Component, Hardware Component, Service Component); End-Use (Patients End-Use, Providers End-Use, Payers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AliveCor
  • Amwell
  • Cardiogram
  • CardioSignal
  • Cardiovascular Health Solutions
  • Cleerly
  • DarioHealth
  • Eko
  • Fitbit
  • HeartFlow
  • Hello Heart
  • Idoven
  • Lark Health
  • Medtronic
  • Omron Healthcare
  • Philips Healthcare
  • Withings
  • Neko Health
  • Story Health
  • WellDoc

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Digital Health for Cardiovascular - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cardiovascular Diseases Drives Demand for Digital Health Solutions in Cardiovascular Care
    • Surge in Remote Patient Monitoring and Telemedicine Adoption Expands Addressable Market for Cardiovascular Digital Health Technologies
    • Technological Advancements in Wearable Devices and Health Monitoring Tools Strengthen the Business Case for Digital Health in Cardiovascular Care
    • Growing Consumer Awareness of Heart Health Accelerates Adoption of Digital Health Solutions for Cardiovascular Disease Prevention
    • Rising Healthcare Costs and Need for Efficient Treatment Models Propel Demand for Digital Health Solutions in Cardiovascular Disease Management
    • Integration of Artificial Intelligence and Machine Learning in Cardiovascular Digital Health Tools Enhances Diagnosis and Treatment Planning
    • Increased Focus on Personalized Healthcare and Precision Medicine Drives Growth in Digital Health Solutions Tailored for Cardiovascular Patients
    • Expansion of Mobile Health Applications and Smartphone Integration Strengthens the Market for Cardiovascular Health Management Tools
    • The Proliferation of Big Data and Predictive Analytics in Cardiovascular Care Accelerates Adoption of Digital Health Platforms for Early Diagnosis
    • Surge in Investment by Governments and Healthcare Providers in Digital Health Infrastructure Drives Market Growth
    • The Integration of IoT in Cardiovascular Health Devices Enables Real-Time Data Collection, Expanding Market Opportunities
    • Regulatory Support for Digital Health Solutions and Remote Monitoring Devices Strengthens Market Confidence and Adoption
    • The Shift Toward Preventative Healthcare and Early Detection Strengthens Demand for Digital Health Solutions in Cardiovascular Care
    • Increasing Need for Chronic Disease Management Solutions Drives Growth in Digital Health Platforms for Long-Term Cardiovascular Care
    • Expansion of Healthcare Networks and Telehealth Programs Creates Opportunities for Cardiovascular Digital Health Solutions in Rural and Underserved Areas
    • The Growth of Cloud Computing and Data Storage Solutions in Healthcare Expands the Scalability and Reach of Digital Health Tools for Cardiovascular Care
    • The Rising Popularity of Fitness and Wellness Tracking Devices Drives Demand for Digital Health Solutions in Cardiovascular Health Management
    • Rising Incidence of Cardiovascular Disease in Aging Populations Expands the Addressable Market for Digital Cardiovascular Health Solutions
    • Regulatory Advances in Digital Health Technologies Create New Opportunities for Compliance-Driven Cardiovascular Health Solutions
    • Increased Focus on Patient Engagement and Empowerment Drives Adoption of Digital Health Tools for Cardiovascular Disease Prevention and Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Digital Health for Cardiovascular Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Digital Health for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Software Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Hardware Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Service Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Service Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Service Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Patients End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Digital Health for Cardiovascular by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Digital Health for Cardiovascular by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Digital Health for Cardiovascular by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Digital Health for Cardiovascular by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제